Analysis of the vitamin D system in cutaneous squamous cell carcinomas

Journal of Cutaneous Pathology

Volumn 31, Issue 3, 2004, Pages 224-231

  Reichrath, Jörg ^a   Rafi, Leyla ^a   Rech, Martin ^a   Mitschele, Tanja ^a   Meineke, Viktor ^b   Gärtner, Barbara C ^a   Tilgen, Wolfgang ^a   Holick, Michael F ^c  

^a SAARLAND UNIVERSITY   (Germany)

^b Sanitatsakademie der Bundeswehr   (Germany)

^c BOSTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,25 DIHYDROXYVITAMIN D 24 HYDROXYLASE; 25 HYDROXYVITAMIN D 1ALPHA HYDROXYLASE; CALCITRIOL; COLECALCIFEROL HYDROXYLASE; RNA; TETRAZOLIUM; UNCLASSIFIED DRUG; VITAMIN D; VITAMIN D DERIVATIVE; VITAMIN D RECEPTOR;

ANALYTIC METHOD; APOPTOSIS; ARTICLE; CANCER GRADING; CELL DIFFERENTIATION; CELL PROLIFERATION; COLORIMETRY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; INCUBATION TIME; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; STAINING; VITAMIN D METABOLISM; VITAMIN SUPPLEMENTATION;

25-HYDROXYVITAMIN D3 1-ALPHA-HYDROXYLASE; APOPTOSIS; CALCITRIOL; CARCINOMA, SQUAMOUS CELL; CELL DIVISION; CELL LINE, TUMOR; CYTOCHROME P-450 CYP27A1; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; RECEPTORS, CALCITRIOL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SKIN NEOPLASMS; STEROID HYDROXYLASES;

EID: 1242315443     PISSN: 03036987     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0303-6987.2003.00183.x     Document Type: Article

References (41)

1. 3: dependence on cell culture conditions. J Invest Dermatol 1996; 294: 510.
2. 3 on the morphologic and biochemical differentiation of cultured human epidermal cells. J Invest Dermatol 1986; 86: 709.
3. Baker AR, McDonnell DP, Hughes M. Cloning and expression of full-length cDNA encoding human vitamin D receptor. Proc Natl Acad Sci USA 1988; 85: 3294.
4. 3 in intestinal tract, stomach, kidney, skin, pituitary and parathyroid. Science 1979; 209: 1189.
5. Haussler MR, Mangelsdorf DJ, Komm BS, et al. Molecular biology of vitamin D hormone. Recent Prog Horm Res 1988; 44: 263.
6. 3 signalling. Nature 1992; 355: 446.
7. Yu VC, Deisert C, Andersen B. RXRβ? A coregulator that enhances binding of retinoic acid, thyroid hormone, and vitamin D receptors to their cognate response elements. Cell 1991; 67: 1251.
8. Leid M, Kastner P, Lyons R. Purification, cloning and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently. Cell 1992; 68: 377.
9. 3 receptors (VDR) in human skin: a comparison of five antibodies. Pathol Res Pract 1996; 192: 281.
10. 3 receptors in human skin. Histochem J 2000; 32: 625.
11. Reichrath J, Müller SM, Kerber A, Baum HP, Bahmer FA. Biologic effects of topical calcipotriol (MC903) treatment in psoriatic skin. J Am Acad Dermatol 1997; 36: 19.
12. 3 leads to induced differentiation of the myelomonocytic cell line U937. Genes Dev 1996; 10: 142.
13. 3. J Biol Chem 1993; 268: 27371.
14. 3 receptor homodimers. J Cell Biochem 1996; 60: 322.
15. 3 (calcitriol) open a new era in cancer therapy? Onkologie 2001; 24: 128.
16. 3 and its analogs on growth control and tumorigenesis. Front Biosci 2001; 6: 820.
17. Henry HL. Vitamin D hydroxylase. J Cell Biochem 1992; 49: 4.
18. Nebert DW, Gonzalez FJ. P450 genes: structure, evolution, and regulation. Annu Rev Biochem 1987; 56: 945.
19. Jones G, Ramshaw H, Zhang A, et al. Expression and activity of vitamin D-metabolizing cytochrome P450s (CYP1α and CYP24) in human nonsmall cell lung carcinomas. Endocrinology 1999; 140: 3303.
20. 3-1α-hydroxylase activity and regulation of side chain metabolism. J Steroid Biochem Mol Biol 1997; 62: 21.
21. Tangpricha V, Flanagan JN, Whitlatch LW, et al. 25-hydroxyvitamin D-1alpha-hydroxylase in normal and malignant colon tissue. Lancet 2001 26; 357: 1673.
22. 3 receptor. Proc Natl Acad Sci USA 1982; 79: 7719.
23. Cattoretti G, Becker MHG, Key G. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB-1 and MIB-3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 1992; 168: 357.
24. Ryle C, Breitkreutz D, Stark HJ, Steinert P, Roop D, Fusenig N. Density-dependent modulation of synthesis of keratins 1 and 10 in the human keratinocyte line HaCaT and in RAS-transfected tumorigenic clones. Differentiation 1989; 40: 42.
25. 3 receptors (VDR) in basal cell carcinomas. Am J Pathol 1999; 155: 583.
26. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992; 119: 493.
27. Boukamp P, Tilgen W, Dzarlieva RT, et al. Phenotypic and genotypic characteristics of a cell line from a squamous cell carcinoma of human skin. J Natl Cancer Inst 1982; 68: 415.
28. Sachs L. Der Vergleich zweier unabhängiger Stichproben: U-Test nach Wilcoxon, Mann and Whitney. In Sachs L, ed. Angewandte Statistik. Berlin, Heidelberg, New York, Tokyo: Springer Verlag, 1997; 230.
29. 3 receptor in target cells. Endocrinology 1988; 122: 1224.
30. 3 receptors in normal human tissues. J Clin Endocrinol Metab 1988; 67: 607.
31. 3: in vitro translation to characterize size and hormone-dependent regulation. Proc Natl Acad Sci USA 1987; 84: 354.
32. Welsh J. Induction of apoptosis in breast cancer cells in response to vitamin D and antiestrogens. Biochem Cell Biol 1994; 11: 537.
33. 3 receptor expression in HaCaT keratinocytes. In Bernd A, Bereiter-Hahn J, Hevert F, Holzmann H, eds. Cell and Tissue Culture Models in Dermatological Research. Berlin, Heidelberg: Springer Verlag, 1993; 37.
34. 3 receptor turnover by dense amino acid labeling: changes during receptor up-regulation by vitamin D metabolites. Endocrinology 1987; 120: 1173.
35. 3. In Norman AW, Bouillon R, Thomasset M, eds. Vitamin D Chemistry, Biology and Clinical Applications of the Steroid Hormone. Riverside, CA, USA: University of California Printing and Reprographics, 1997; 581.
36. 3 metabolism in human skin. J Invest Dermatol 1997; 108: 78.
37. 3 results from ligand-induced stabilization. J Biol Chem 1992; 267: 20082.
38. Bilde DD, Pillai S, Gee E. Squamous carcinoma cell lines produce 1,25 dihydroxyvitamin D, but fail to respond to its prodifferentiating effect. J Invest Dermatol 1991; 97: 435.
39. Ratnam AV, Bikle DD, Su MJ, Pillai S. Squamous carcinoma cell lines fail to respond to 1,25-Dihydroxyvitamin D despite normal levels of the vitamin D receptor. J Invest Dermatol 1996; 106: 522.
40. Albertson DG, Ylstra B, Segraves R, et al. Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene. Nat Genet 2000; 25: 144.
41. Majewski S, Skopinska M, Bollag W, Jablonska S. Combination of isotretinoin and calcitriol for precancerous and cancerous skin lesions. Lancet 1994; 344: 1510.